Chronic Intestinal Pseudo-obstruction and Orthostatic Hypotension Associated with Small Cell Lung Cancer that Improved with Tumor Reduction after Chemoradiotherapy

被引：8

作者：

Izumi, Yusuke ^{[1
]}

Masuda, Takeshi ^{[1
]}

Horimasu, Yasushi ^{[1
]}

Nakashima, Taku ^{[1
]}

Miyamoto, Shintaro ^{[1
]}

Iwamoto, Hiroshi ^{[1
]}

Fujitaka, Kazunori ^{[1
]}

Hamada, Hironobu ^{[1
]}

Hattori, Noboru ^{[1
]}

机构：

[1] Hiroshima Univ Hosp, Dept Resp Internal Med, Hiroshima, Japan

来源：

INTERNAL MEDICINE | 2017年 / 56卷 / 19期

关键词：

chronic intestinal pseudo-obstruction; small cell lung cancer; paraneoplastic neurological syndrome; orthostatic hypotension; anti-Hu antibody; PARANEOPLASTIC NEUROLOGICAL SYNDROMES; ANTI-HU ANTIBODIES; CRITERIA;

D O I：

10.2169/internalmedicine.8574-16

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Chronic intestinal pseudo-obstruction (CIPO) is a rare disease with symptoms of ileus without obstruction. Most cases of CIPO are idiopathic, and CIPO as a paraneoplastic neurological syndrome (PNS) associated with small cell lung cancer (SCLC) is rare. A 63-year-old man was diagnosed with functional ileus and confined to bed due to orthostatic hypotension. Chest computed tomography revealed a right hilar mass suspected of being lung cancer. Based on detailed examinations, he was diagnosed with limited-stage SCLC. His symptoms were confirmed as PNS because his serum anti-Hu antibody was positive. His PNS was improved with complete tumor reduction by chemoradiotherapy.

引用

页码：2627 / 2631

页数：5

共 12 条

[1] Graus F, 2004, J NEUROL NEUROSUR PS, V75, P1135, DOI 10.1136/jnnp.2003.034447
[2] Anti-Hu antibodies in patients with small-cell lung cancer: Association with complete response to therapy and improved survival
Graus, F
Dalmau, J
Rene, R
Tora, M
Malats, N
Verschuuren, JJ
Cardenal, F
Vinolas, N
delMuro, JG
Vadell, C
Mason, WP
Rosell, R
Posner, JB
Real, FX
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (08) : 2866 - 2872
[3] A review of the reported cases of chronic intestinal pseudo-obstruction in Japan and an investigation of proposed new diagnostic criteria
Iida H.
Inamori M.
Sekino Y.
Sakamoto Y.
Yamato S.
Nakajima A.
[J]. Clinical Journal of Gastroenterology, 2011, 4 (3) : 141 - 146
[4] Lee HR, 2001, AM J GASTROENTEROL, V96, P373
[5] Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies
Lucchinetti, CF
Kimmel, DW
Lennon, VA
[J]. NEUROLOGY, 1998, 50 (03) : 652 - 657
[6] Mifune Daiki, 2010, Nihon Kokyuki Gakkai Zasshi, V48, P439
[7] Small cell lung cancer with positive anti-Hu antibodies presenting as gastroparesis
Moskovitz, DN
Robb, KV
[J]. CANADIAN JOURNAL OF GASTROENTEROLOGY, 2002, 16 (03): : 171 - 174
[8] TOXICITY AND RESPONSE CRITERIA OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP
OKEN, MM
CREECH, RH
TORMEY, DC
HORTON, J
DAVIS, TE
MCFADDEN, ET
CARBONE, PP
[J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (06): : 649 - 655
[9] Octreotide treatment for paraneoptastic intestinal pseudo-obstruction complicating SCLC
Sorhaug, S
Steinshamn, SL
Waldum, HL
[J]. LUNG CANCER, 2005, 48 (01) : 137 - 140
[10] The great masquerader of malignancy: Chronic intestinal pseudo-obstruction
Taverna J.A.
Babiker H.M.
Yun S.
Bishop M.C.
Lau-Braunhut S.
Meyer P.N.
Enzler T.
[J]. Biomarker Research, 2 (1)

← 1 2 →